Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Gordon Haskett Downgrades Dollar Tree to Accumulate

Gordon Haskett Downgrades Dollar Tree to Accumulate

Gordon Haskett analyst Chuck Grom downgrades Dollar Tree (NASDAQ:DLTR) from Buy to Accumulate.

byBenzinga Newsdesk

January 24, 2023

1 minute read

Gordon Haskett analyst Chuck Grom downgrades Dollar Tree (NASDAQ:DLTR) from Buy to Accumulate.

Truist Securities Maintains Buy on Privia Health Group, Raises Price Target to $40

By Benzinga Newsdesk

July 14, 8:13 AM

Truist Securities analyst David Macdonald maintains Privia Health Group (NASDAQ:PRVA) with a Buy and raises the price target from $36 to $40.

PRVA

Needham Reiterates Buy on Cara Therapeutics, Maintains $26 Price Target

By Benzinga Newsdesk

February 17, 7:49 AM

Needham analyst Joseph Stringer reiterates Cara Therapeutics (NASDAQ:CARA) with a Buy and maintains $26 price target.

CARA

Citigroup Disbands Global FX Strategy Team, Signals Major Structural Changes

By Vandana Singh

June 8, 1:39 PM

Citigroup Inc (NYSE: C) has reportedly disbanded its CitiFX global FX strategy team responsible for providing commentary and analysis on foreign exchange (FX) markets.

SVB Leerink Maintains Outperform on Tenet Healthcare, Lowers Price Target to $68

By Benzinga Newsdesk

July 15, 6:57 AM

SVB Leerink analyst Whit Mayo maintains Tenet Healthcare (NYSE:THC) with a Outperform and lowers the price target from $110 to $68.

THC

Gordon Haskett Downgrades Dollar Tree to Accumulate

Related Posts

Truist Securities Maintains Buy on Privia Health Group, Raises Price Target to $40

Needham Reiterates Buy on Cara Therapeutics, Maintains $26 Price Target

Citigroup Disbands Global FX Strategy Team, Signals Major Structural Changes

SVB Leerink Maintains Outperform on Tenet Healthcare, Lowers Price Target to $68